The Role of Cardiac Myosin Binding Protein C3 in Hypertrophic Cardiomyopathy- Progress and Novel Therapeutic Opportunities
| Author | Mohamed, Iman A. |
| Author | Krishnamoorthy, Navaneethakrishnan T. |
| Author | Nasrallah, Gheyath K. |
| Author | Da'as, Sahar |
| Available date | 2016-10-26T06:32:01Z |
| Publication Date | 2016-10-12 |
| Publication Name | Journal of Cellular Physiology |
| Identifier | http://dx.doi.org/10.1002/jcp.25639 |
| Citation | Mohamed, I. A., Krishnamoorthy, N. T., Nasrallah, G. K. and Da'as, S. (2016), The Role of Cardiac Myosin Binding Protein C3 in Hypertrophic Cardiomyopathy- Progress and Novel Therapeutic Opportunities. J. Cell. Physiol.. Accepted Author Manuscript. |
| ISSN | 0021-9541 |
| Abstract | Hypertrophic cardiomyopathy (HCM) is a common autosomal dominant genetic cardiovascular disorder marked by genetic and phenotypic heterogeneity. Mutations in the gene encodes the cardiac myosin-binding protein C, cMYBPC3 is amongst the various sarcomeric genes that are associated with HCM. These mutations produce mutated mRNAs and truncated cMyBP-C proteins. In this review, we will discuss the implications and molecular mechanisms involved in MYBPC3 different mutations. Further, we will highlight the novel targets that can be developed into potential therapeutics for the treatment of HMC. This article is protected by copyright. All rights reserved |
| Language | en |
| Publisher | Wiley |
| Subject | Myosin Cardiomyopathy Hypertrophy |
| Type | Article |
| ESSN | 1097-4652 |
Files in this item
This item appears in the following Collection(s)
-
Biomedical Research Center Research [666 items ]
-
Biomedical Sciences [646 items ]